Reports

Posted in Annual reports, and Data tables in reports.

State of the Nation Report, January 2024

In our first State of the Nation Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2020 and March 2022 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.

Posted in Annual reports, and Data tables in reports.

2022 Annual Report

In our 14th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2019 and March 2021 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.

Posted in Annual reports, and Data tables in reports.

2021 Annual Report

In our 13th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2018 and March 2020 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.

Posted in Annual reports, and Data tables in reports.

2020 Annual Report

In our 12th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2017 and March 2019 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.

Posted in Annual reports, and Data tables in reports.

2019 Annual Report

In our 11th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2016 and March 2018, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia.

Posted in Annual reports.

2018 Annual Report

In our 10th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2015 and March 2017, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high-grade dysplasia.

Posted in Annual reports.

2017 Annual Report

This is our 9th annual report. It covers patients diagnosed with oesophageal or gastric cancer between April 2014 and March 2016 (from 2013 for surgical topics) and patients with high grade dysplasia diagnosed between April 2012 and March 2016.